Sangon Biotech Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 877

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

  • Investments
  • 1

Sangon Biotech General Information

Description

Provider of life science research products and laboratory services intended for biological research and diagnostic applications. The company provides nucleic acid synthesis, gene synthesis, DNA sequencing, protein services, molecular biology testing, and research consumables, enabling research institutions and pharmaceutical companies to conduct biological analyses and laboratory workflows.

Contact Information

Website
www.sangon.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Number 698 Xiangmin Road
  • Songjiang District
  • Shanghai, 201611
  • China
+86 400
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • Number 698 Xiangmin Road
  • Songjiang District
  • Shanghai, 201611
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sangon Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sangon Biotech‘s full profile, request access.

Request a free trial

Sangon Biotech Patents

Sangon Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025189691-A1 Method for synthesizing n2-c6 amino-modified deoxyguanosine monomer Pending 11-Mar-2024
WO-2025123773-A1 Detection method for rare-mutation braf gene Inactive 15-Dec-2023
WO-2025118706-A1 Double-stranded dna adapter and detection method for short dna fragments Inactive 06-Dec-2023
WO-2025112711-A1 Protein molecular weight standard reference substance and preparation method therefor Inactive 29-Nov-2023
WO-2025107775-A1 Recombinant streptococcus protein g, affinity chromatography resin, and use thereof Inactive 24-Nov-2023 C07K14/315
To view Sangon Biotech’s complete patent history, request access »

Sangon Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sangon Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sangon Biotech‘s full profile, request access.

Request a free trial

Sangon Biotech Acquisitions (1)

Sangon Biotech’s most recent deal was a Merger/Acquisition with Okay Biotechnology. The deal was made on 11-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Okay Biotechnology 11-Dec-2025 Merger/Acquisition Biotechnology
To view Sangon Biotech’s complete acquisitions history, request access »

Sangon Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
BBI Life Sciences Shanghai, China 2001

Sangon Biotech FAQs

  • When was Sangon Biotech founded?

    Sangon Biotech was founded in 2003.

  • Where is Sangon Biotech headquartered?

    Sangon Biotech is headquartered in Shanghai, China.

  • What is the size of Sangon Biotech?

    Sangon Biotech has 877 total employees.

  • What industry is Sangon Biotech in?

    Sangon Biotech’s primary industry is Biotechnology.

  • Is Sangon Biotech a private or public company?

    Sangon Biotech is a Private company.

  • What is Sangon Biotech’s current revenue?

    The current revenue for Sangon Biotech is .

  • How much funding has Sangon Biotech raised over time?

    Sangon Biotech has raised $297M.

  • Who are Sangon Biotech’s investors?

    CDB Venture, CPE Funds Management, GL Capital Group, Greenwoods Investment, and Huagai Capital are 5 of 7 investors who have invested in Sangon Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process